Cargando…

Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies

BACKGROUND AND OBJECTIVES: Little is known about the efficacy and durability of anti-RBD IgG antibodies induced by certain SARS-CoV-2 vaccines. It has been shown that neutralizing antibodies are associated with the protection against re-infection. This study aims to compare the mean titers, duration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sughayer, M.A., Souan, L., Abu Alhowr, M.M., Al Rimawi, D., Siag, M., Albadr, S., Owdeh, M., Al Atrash, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971065/ https://www.ncbi.nlm.nih.gov/pubmed/35397946 http://dx.doi.org/10.1016/j.vaccine.2022.03.069

Ejemplares similares

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
por: Souan, Lina, et al.
Publicado: (2022)

An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations
por: Souan, Lina, et al.
Publicado: (2022)

Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan
por: Souan, Lina, et al.
Publicado: (2021)

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
por: Sughayer, Maher A., et al.
Publicado: (2021)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
por: Pérez-Bernal, Maylin, et al.
Publicado: (2022)

Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022)

Anti-RBD IgA and IgG Response and Transmission in Breast Milk of Anti-SARS-CoV-2 Vaccinated Mothers
por: Trofin, Felicia, et al.
Publicado: (2022)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2023)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement
por: Abu-Humaidan, Anas H. A., et al.
Publicado: (2022)

Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination
por: Snodgrass, D.R., et al.
Publicado: (1995)

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
por: Lo Sasso, Bruna, et al.
Publicado: (2021)

Levels of SARS-COV-2 anti-spike protein receptor-binding domain (S-RBD) IgG in Indonesian-vaccinated healthcare workers: experimental research
por: Tambunan, Betty A., et al.
Publicado: (2023)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant
por: Chang, Chih-Chao, et al.
Publicado: (2021)

COVID-19 vaccination and IgG and IgA antibody dynamics in healthcare workers
por: Zurac, Sabina, et al.
Publicado: (2021)

Thirteen-Valent Pneumococcal Conjugate Vaccine–Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the Lung
por: Mitsi, Elena, et al.
Publicado: (2021)

Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine
por: Lo Sasso, Bruna, et al.
Publicado: (2022)

Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG
por: de Voer, Richarda M., et al.
Publicado: (2011)

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
por: Azzi, Lorenzo, et al.
Publicado: (2021)

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
por: Takheaw, Nuchjira, et al.
Publicado: (2022)

A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study
por: Serra, Nicola, et al.
Publicado: (2023)

Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response
por: Ash, Michelle K., et al.
Publicado: (2022)

Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
por: Liao, Baolin, et al.
Publicado: (2021)

Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
por: González-Stegmaier, R., et al.
Publicado: (2021)

Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
por: Indenbaum, Victoria, et al.
Publicado: (2020)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Evaluation of S1RBD-Specific IgG Antibody Responses following COVID-19 Vaccination in Healthcare Professionals in Cyprus: A Comparative Look between the Vaccines of Pfizer-BioNTech and AstraZeneca
por: Deeba, Elie, et al.
Publicado: (2022)

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Anti-SARS-CoV-2 S-RBD IgG Antibody Responses after COVID-19 mRNA Vaccine in the Chronic Disorder of Consciousness: A Pilot Study
por: Pugliese, Maria Elena, et al.
Publicado: (2021)

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)

Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses
por: Haghighi, Melika, et al.
Publicado: (2022)

Induction of food-specific IgG by Gene Gun-delivered DNA vaccines
por: Smeekens, Johanna M., et al.
Publicado: (2022)

Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune
por: Timofeeva, Anna M., et al.
Publicado: (2022)

Comparable diagnostic accuracy of SARS-CoV-2 Spike RBD and N-specific IgG tests to determine pre-vaccination nation-wide baseline seroprevalence in Mexico
por: Martínez-Barnetche, Jesús, et al.
Publicado: (2022)

Non-Dexamethasone Corticosteroid Therapy’s Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study
por: Souan, Lina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p22ct28ka4hbjb2n40ks3da335